M Dworkind, A Towers, D Murnaghan, R Guibert, D Iverson
{"title":"Communication between family physicians and oncologists: qualitative results of an exploratory study.","authors":"M Dworkind, A Towers, D Murnaghan, R Guibert, D Iverson","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To study communication between family physicians (FPs) and oncologists, and to look at the factors that may influence FP involvement in cancer care.</p><p><strong>Design: </strong>This survey design uses a qualitative methodology, where the data are analyzed using a modified grounded theory approach.</p><p><strong>Setting: </strong>This was a multisite study using 14 focus groups of FPs, followed by structured telephone interviews with 116 FPs in 6 different Canadian provinces.</p><p><strong>Main outcome measure: </strong>Interview questions were used to explore the actual and desired roles of FPs in cancer care, and the quality of communication with oncologists with reference to a particular cancer patient in the FPs' practice.</p><p><strong>Results: </strong>Physicians providing cancer care must consider complex psychosocial and biomedical factors, more so than with other chronic diseases, and so written communication alone is inadequate. Family physicians require face-to-face and/or telephone communication with the oncologist to negotiate their respective roles, and to discuss the patient's prognosis and the effectiveness of proposed treatments. Family physicians expressed a desire to become more involved in all stages of cancer care in both the biomedical and psychosocial aspects, and to help better define their roles throughout the illness trajectory.</p><p><strong>Conclusion: </strong>These results suggest opportunities to improve the communication, coordination and comprehensiveness of shared cancer care provided by family physicians and oncologists in different clinical settings.</p>","PeriodicalId":79570,"journal":{"name":"Cancer prevention & control : CPC = Prevention & controle en cancerologie : PCC","volume":"3 2","pages":"137-44"},"PeriodicalIF":0.0000,"publicationDate":"1999-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer prevention & control : CPC = Prevention & controle en cancerologie : PCC","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To study communication between family physicians (FPs) and oncologists, and to look at the factors that may influence FP involvement in cancer care.
Design: This survey design uses a qualitative methodology, where the data are analyzed using a modified grounded theory approach.
Setting: This was a multisite study using 14 focus groups of FPs, followed by structured telephone interviews with 116 FPs in 6 different Canadian provinces.
Main outcome measure: Interview questions were used to explore the actual and desired roles of FPs in cancer care, and the quality of communication with oncologists with reference to a particular cancer patient in the FPs' practice.
Results: Physicians providing cancer care must consider complex psychosocial and biomedical factors, more so than with other chronic diseases, and so written communication alone is inadequate. Family physicians require face-to-face and/or telephone communication with the oncologist to negotiate their respective roles, and to discuss the patient's prognosis and the effectiveness of proposed treatments. Family physicians expressed a desire to become more involved in all stages of cancer care in both the biomedical and psychosocial aspects, and to help better define their roles throughout the illness trajectory.
Conclusion: These results suggest opportunities to improve the communication, coordination and comprehensiveness of shared cancer care provided by family physicians and oncologists in different clinical settings.